Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus first generation drug-eluting balloon. A balanced comparison?

Affiliations

Comment

Davide Piraino. Int J Cardiol. 2017.

. 2017 Sep 1:242:6.

doi: 10.1016/j.ijcard.2017.01.100.

¹ Interventional Cardiology, "P. Giaccone" Universitary Hospital of Palermo, Italy. Electronic address: pirainod@libero.it.

No abstract available

Comment in

Paclitaxel eluting balloon and sirolimus eluting balloon, many weapons against a common enemy: The in-stent restenosis.
Piraino D. Piraino D. Int J Cardiol. 2017 Sep 1;242:4. doi: 10.1016/j.ijcard.2017.03.035. Int J Cardiol. 2017. PMID: 28619341 No abstract available.
Treatment for in-stent restenosis using drug-eluting balloon: Importance of procedural optimization rather than device itself.
Lee JM, Rhee TM, Park J, Kim HS. Lee JM, et al. Int J Cardiol. 2017 Sep 1;242:5. doi: 10.1016/j.ijcard.2017.02.110. Int J Cardiol. 2017. PMID: 28619351 No abstract available.

Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
Lee JM, Rhee TM, Hahn JY, Hwang D, Park J, Park KW, Kim HL, Kim SH, Chae IH, Doh JH, Jeon KH, Choi YJ, Park JS, Choi SH, Gwon HC, Koo BK, Alfonso F, Kim HS. Lee JM, et al. Int J Cardiol. 2017 Mar 1;230:181-190. doi: 10.1016/j.ijcard.2016.12.176. Epub 2016 Dec 29. Int J Cardiol. 2017. PMID: 28043660